Investigational ovarian cancer drug shows promise against platinum resistant disease
Sunday, October 10, 2010 - 04:50
in Health & Medicine
A drug being developed as a treatment for ovarian cancer has shown single agent activity with durable disease control in some patients in a Phase-II clinical trial, an international research group has reported.